• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 REACT CATHETER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 REACT CATHETER; CATHETER, PERCUTANEOUS Back to Search Results
Model Number REACT-68
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intracranial Hemorrhage (1891); Cerebral Edema (4403)
Event Date 02/28/2024
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received a report that the patient experienced superficial and deep sylvian hemorrhagic remodeling on 24 hour computerized tomography (ct).  the rationale for relating the adverse event (ae) to system or procedure was intracerebral hemorrhage, remote (rih).The patient's baseline modified rankin scale (mrs) score was 2, and baseline national institutes of health stroke scale (nihss) score was 18.The onset date was (b)(6) 2024 and the patient is recovering, and the issue resolving.The ae had a causal relationship with the disease under study.Ae not related to underlying condition or device deficiency.This event did not lead to congenital anomaly, death, disability, hospitalization, or medical intervention and was not considered life-threatening.The site assessed this event as not related to the study device or procedure.The sponsor assessed this event as possibly related to the study procedure.Additional information was received reporting the patient experienced cerebral mass effect with discrete midline deviation to the left on 24 hour computerized tomography (ct).The onset date was (b)(6) 2024 and the issue recovered/resolved on 2024-03-02.This adverse event (ae) had a causal relationship to the disease under study.Ae was not related to underlying condition or disease and did not result from a device deficiency.The patient's baseline modified rankin scale (mrs) score was 2, and baseline national institutes of health stroke scale (nihss) score was 18.Per site, this event did not lead to congenital anomaly, death, disability, hospitalization, or medical intervention, and was not considered life-threatening.The site assessed this event as not related to the study device or procedure.The sponsor assessed this event as possibly related to the study procedure.Pre-procedure mtici score 0, final post-procedure mtici score 3.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information received reported no decline in the nihss noted at 24-h post-procedure visit as baseline nihss 18, 24h fu visit (b)(6) 2024, nihss 7 and on discharge (b)(6)2024 nihss 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REACT CATHETER
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18980571
MDR Text Key338659908
Report Number2029214-2024-00512
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K180715
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberREACT-68
Device Catalogue NumberREACT-68
Device Lot NumberB429851
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/19/2024
Initial Date FDA Received03/26/2024
Supplement Dates Manufacturer Received03/27/2024
Supplement Dates FDA Received04/08/2024
Date Device Manufactured08/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
Patient Weight39 KG
-
-